JPMorgan Healthcare Leaders ETF is a ETF series of J.P. Morgan Exchange-Traded Fund Trust (series S000080528). Net assets $11.1M as of 2026-04-30.
Showing 15 of 66 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $758K | 681.31% |
| AbbVie, Inc. | — | $732K | 657.99% |
| Johnson & Johnson | — | $690K | 620.03% |
| UnitedHealth Group, Inc. | — | $649K | 583.11% |
| AstraZeneca plc | — | $508K | 456.53% |
| Merck & Co., Inc. | — | $468K | 420.92% |
| Bristol-Myers Squibb Co. | — | $389K | 350.03% |
| Thermo Fisher Scientific, Inc. | — | $354K | 318.59% |
| Intuitive Surgical, Inc. | — | $329K | 295.75% |
| CVS Health Corp. | — | $301K | 270.87% |
| Novo Nordisk A/S | — | $295K | 265.46% |
| Roche Holding AG | — | $295K | 264.83% |
| Hoya Corp. | — | $261K | 235.00% |
| Regeneron Pharmaceuticals, Inc. | — | $243K | 218.63% |
| Boston Scientific Corp. | — | $227K | 204.34% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $11.1M |
| 2026-01-31 | $8.8M |
| 2025-10-31 | $8.2M |
| 2025-07-31 | $7.4M |
| 2025-04-30 | $7.8M |
| 2025-01-31 | $8.2M |
| 2024-10-31 | $7.2M |
| 2024-07-31 | $7.5M |